United Therapeutics Quarterly Balance Sheets Chart
Quarterly
|
Annual
United Therapeutics Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-09-30 | 2011-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||||||||||||||||||||||||||||||||||
| current assets: | |||||||||||||||||||||||||||||||||||||||||||||||||
| cash and cash equivalents | 1,593,100,000 | 1,899,900,000 | 1,697,200,000 | 1,553,900,000 | 1,355,700,000 | 1,251,500,000 | 1,207,700,000 | 1,107,700,000 | 1,067,300,000 | 1,163,500,000 | 961,200,000 | 966,800,000 | 795,200,000 | 813,300,000 | 894,800,000 | 908,500,000 | 942,200,000 | 832,300,000 | 738,700,000 | 670,200,000 | 685,400,000 | 875,200,000 | 738,400,000 | 719,700,000 | 881,300,000 | 790,600,000 | 656,000,000 | 745,900,000 | 932,700,000 | 1,067,500,000 | 1,005,900,000 | 1,122,600,000 | 953,000,000 | 837,500,000 | 846,800,000 | 765,205,000 | 254,359,000 | 426,509,000 | 497,291,000 | 259,046,000 | 413,794,000 | 322,230,000 | 343,550,000 | 262,126,000 | 263,425,000 | 157,013,000 | 156,666,000 | 343,984,000 | 321,121,000 |
| marketable investments | 1,455,600,000 | 1,421,400,000 | 1,569,800,000 | 1,772,600,000 | 1,615,800,000 | 1,456,300,000 | 1,786,400,000 | 1,767,800,000 | 1,611,700,000 | 1,699,900,000 | 1,877,500,000 | 1,648,800,000 | 1,460,000,000 | 1,454,400,000 | 1,035,900,000 | 1,091,900,000 | 1,025,300,000 | 899,000,000 | 1,096,300,000 | 910,300,000 | 875,300,000 | 669,300,000 | 747,500,000 | 850,300,000 | 904,900,000 | 814,500,000 | 581,600,000 | 467,100,000 | 324,100,000 | 143,200,000 | 109,300,000 | 33,700,000 | 79,600,000 | 107,200,000 | 128,300,000 | 156,630,000 | 185,774,000 | 230,356,000 | 270,372,000 | 308,534,000 | 346,698,000 | 394,612,000 | 353,041,000 | 408,516,000 | 240,032,000 | 235,355,000 | 252,300,000 | 350,614,000 | 409,098,000 |
| accounts receivable, no allowance for 2025 and 2024 | 379,300,000 | 322,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| inventories | 169,200,000 | 165,400,000 | 157,900,000 | 146,700,000 | 136,500,000 | 120,200,000 | 111,800,000 | 104,300,000 | 103,300,000 | 102,500,000 | 102,000,000 | 91,000,000 | 89,900,000 | 88,200,000 | 93,800,000 | 96,700,000 | 89,900,000 | 92,200,000 | 86,500,000 | 87,900,000 | 89,700,000 | 92,000,000 | 93,400,000 | 94,100,000 | 96,900,000 | 96,200,000 | 101,000,000 | 102,700,000 | 101,500,000 | 114,400,000 | 114,100,000 | 106,900,000 | 92,400,000 | 89,100,000 | 87,600,000 | 80,844,000 | 77,249,000 | 72,465,000 | 63,669,000 | 58,033,000 | 51,717,000 | 49,617,000 | 44,713,000 | 39,743,000 | 46,848,000 | 46,631,000 | 45,760,000 | 45,797,000 | 41,260,000 |
| other current assets | 229,700,000 | 131,100,000 | 169,700,000 | 185,400,000 | 220,800,000 | 113,400,000 | 166,200,000 | 220,500,000 | 158,400,000 | 92,600,000 | 219,200,000 | 118,100,000 | 165,800,000 | 60,200,000 | 100,400,000 | 76,000,000 | 87,100,000 | 49,700,000 | 88,300,000 | 47,500,000 | 72,000,000 | 60,200,000 | 133,800,000 | 85,700,000 | 75,700,000 | 81,400,000 | 54,900,000 | 57,200,000 | 64,200,000 | 62,300,000 | 60,500,000 | 52,900,000 | 36,400,000 | 43,500,000 | 42,100,000 | 46,202,000 | 142,443,000 | 108,608,000 | 107,250,000 | 43,093,000 | 46,288,000 | 35,641,000 | 5,013,000 | 5,838,000 | 37,390,000 | 24,825,000 | 21,844,000 | 6,277,000 | 11,037,000 |
| total current assets | 3,826,900,000 | 3,939,800,000 | 3,873,900,000 | 4,000,400,000 | 3,619,500,000 | 3,248,700,000 | 3,551,000,000 | 3,458,900,000 | 3,213,400,000 | 3,193,000,000 | 3,380,300,000 | 3,056,400,000 | 2,684,300,000 | 2,586,600,000 | 2,323,600,000 | 2,385,900,000 | 2,317,900,000 | 2,014,300,000 | 2,167,200,000 | 1,868,200,000 | 1,894,400,000 | 1,846,300,000 | 1,864,500,000 | 1,933,400,000 | 2,139,800,000 | 1,942,500,000 | 1,608,700,000 | 1,624,200,000 | 1,633,600,000 | 1,639,200,000 | 1,563,700,000 | 1,504,100,000 | 1,386,000,000 | 1,315,400,000 | 1,299,600,000 | 1,228,523,000 | 829,039,000 | 994,091,000 | 1,078,485,000 | 881,608,000 | 990,268,000 | 932,742,000 | 903,583,000 | 844,567,000 | 718,185,000 | 570,607,000 | 573,919,000 | 846,133,000 | 877,509,000 |
| goodwill and other intangible assets | 111,500,000 | 111,700,000 | 111,900,000 | 112,100,000 | 115,200,000 | 115,400,000 | 114,200,000 | 44,400,000 | 44,500,000 | 44,500,000 | 44,500,000 | 44,500,000 | 44,600,000 | 44,600,000 | 44,600,000 | 44,700,000 | 44,700,000 | 44,700,000 | 158,100,000 | 158,200,000 | 158,200,000 | 158,300,000 | 158,300,000 | 158,400,000 | 161,900,000 | 170,800,000 | 167,700,000 | 45,600,000 | 45,600,000 | 45,700,000 | 45,800,000 | 33,600,000 | 34,000,000 | 34,100,000 | 34,300,000 | ||||||||||||||
| property, plant, and equipment | 1,362,400,000 | 1,302,700,000 | 1,222,400,000 | 1,156,700,000 | 1,094,600,000 | 1,074,000,000 | 1,045,400,000 | 992,200,000 | 938,900,000 | 896,500,000 | 861,500,000 | 840,800,000 | 791,400,000 | 784,400,000 | 780,900,000 | 726,700,000 | 715,700,000 | 713,700,000 | 731,600,000 | 736,400,000 | 744,200,000 | 739,200,000 | 488,400,000 | 490,600,000 | 495,200,000 | ||||||||||||||||||||||||
| deferred tax assets | 456,200,000 | 456,600,000 | 458,400,000 | 390,900,000 | 395,600,000 | 396,100,000 | 394,800,000 | 325,600,000 | 325,600,000 | 321,900,000 | 327,700,000 | 281,300,000 | 275,300,000 | 271,800,000 | 261,900,000 | 273,900,000 | 264,200,000 | 263,600,000 | 238,600,000 | 255,500,000 | 245,800,000 | 246,100,000 | 230,000,000 | 268,100,000 | 264,300,000 | 265,500,000 | 112,900,000 | 113,400,000 | 113,400,000 | 177,900,000 | 178,000,000 | 181,500,000 | 188,800,000 | 188,100,000 | 192,500,000 | 182,600,000 | 182,719,000 | 182,716,000 | 193,653,000 | 193,808,000 | 193,910,000 | 149,648,000 | 14,554,000 | 14,554,000 | 8,199,000 | 8,199,000 | 8,199,000 | 2,309,000 | 2,309,000 |
| other non-current assets | 233,300,000 | 222,400,000 | 222,100,000 | 183,600,000 | 167,900,000 | 169,100,000 | 151,800,000 | 141,700,000 | 135,300,000 | 124,500,000 | 114,300,000 | 114,800,000 | 105,800,000 | 113,300,000 | 108,200,000 | 109,000,000 | 177,000,000 | 171,200,000 | 169,900,000 | 165,400,000 | 167,400,000 | 168,000,000 | 154,600,000 | 231,000,000 | 202,900,000 | 235,400,000 | 261,700,000 | 257,300,000 | 235,300,000 | 213,000,000 | 185,900,000 | 204,100,000 | |||||||||||||||||
| total assets | 7,908,000,000 | 7,743,900,000 | 7,364,000,000 | 7,123,100,000 | 6,723,200,000 | 6,495,200,000 | 7,167,000,000 | 7,023,600,000 | 6,681,300,000 | 6,346,000,000 | 6,044,500,000 | 5,781,600,000 | 5,543,300,000 | 5,359,800,000 | 5,169,100,000 | 5,048,900,000 | 4,844,900,000 | 4,641,000,000 | 4,615,000,000 | 4,411,200,000 | 4,219,400,000 | 4,025,900,000 | 3,913,400,000 | 3,999,600,000 | 3,898,900,000 | 3,726,700,000 | 3,412,100,000 | 3,244,900,000 | 3,020,200,000 | 2,936,000,000 | 2,691,500,000 | 2,561,300,000 | 2,269,200,000 | 2,201,500,000 | 2,192,100,000 | 2,159,233,000 | 1,736,822,000 | 1,894,614,000 | 2,072,050,000 | 1,952,872,000 | 2,114,934,000 | 1,927,657,000 | 1,777,673,000 | 1,697,355,000 | 1,647,492,000 | 1,556,401,000 | 1,561,435,000 | 1,667,053,000 | 1,578,740,000 |
| liabilities and stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||
| current liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||
| accounts payable and accrued expenses | 432,000,000 | 367,000,000 | 344,500,000 | 363,900,000 | 325,300,000 | 305,100,000 | 298,000,000 | 333,400,000 | 292,000,000 | 239,700,000 | 229,900,000 | 220,100,000 | 196,600,000 | 166,400,000 | 174,600,000 | 210,500,000 | 189,800,000 | 165,000,000 | 187,000,000 | 177,100,000 | 152,600,000 | 130,300,000 | 148,400,000 | 161,100,000 | 163,900,000 | 139,400,000 | 204,800,000 | 216,000,000 | 203,400,000 | 143,300,000 | 126,800,000 | 105,600,000 | 119,000,000 | 124,000,000 | 106,600,000 | 113,346,000 | 110,110,000 | 90,130,000 | 127,961,000 | 112,246,000 | 104,015,000 | 97,510,000 | |||||||
| line of credit | 200,000,000 | 300,000,000 | 400,000,000 | 400,000,000 | 400,000,000 | 400,000,000 | 300,000,000 | 800,000,000 | 800,000,000 | 800,000,000 | 800,000,000 | 800,000,000 | 800,000,000 | 800,000,000 | 800,000,000 | 800,000,000 | 800,000,000 | 250,000,000 | 250,000,000 | 250,000,000 | 1,050,000,000 | 250,000,000 | 250,000,000 | 250,000,000 | 250,000,000 | 250,000,000 | |||||||||||||||||||||||
| other current liabilities | 95,100,000 | 154,500,000 | 82,600,000 | 80,100,000 | 77,800,000 | 126,300,000 | 71,000,000 | 70,100,000 | 37,800,000 | 38,600,000 | 32,500,000 | 35,700,000 | 39,600,000 | 60,800,000 | 28,400,000 | 26,000,000 | 24,800,000 | 30,300,000 | 39,500,000 | 49,600,000 | 41,400,000 | 45,000,000 | 39,600,000 | 40,500,000 | 31,900,000 | 53,100,000 | 77,900,000 | 62,300,000 | 32,200,000 | 251,000,000 | 270,000,000 | 104,000,000 | 60,900,000 | 46,600,000 | 103,100,000 | 199,962,000 | 45,243,000 | 48,964,000 | 39,519,000 | 19,074,000 | 61,381,000 | 158,432,000 | 110,955,000 | 99,072,000 | 129,850,000 | 111,756,000 | 108,617,000 | 89,542,000 | 130,235,000 |
| total current liabilities | 527,100,000 | 721,500,000 | 738,100,000 | 873,400,000 | 832,300,000 | 860,600,000 | 804,400,000 | 744,100,000 | 370,300,000 | 324,600,000 | 343,200,000 | 315,900,000 | 331,500,000 | 292,600,000 | 305,400,000 | 320,000,000 | 311,400,000 | 302,400,000 | 323,300,000 | 258,900,000 | 255,000,000 | 207,300,000 | 463,000,000 | 469,900,000 | 463,500,000 | 270,000,000 | 372,400,000 | 350,000,000 | 318,400,000 | 789,400,000 | 838,800,000 | 427,700,000 | 314,600,000 | 292,400,000 | 357,100,000 | 557,342,000 | 542,414,000 | 646,748,000 | 760,648,000 | 659,073,000 | 658,535,000 | 468,909,000 | 412,225,000 | 176,604,000 | 227,615,000 | 187,662,000 | 175,542,000 | 424,951,000 | 453,541,000 |
| other non-current liabilities | 207,300,000 | 215,200,000 | 181,900,000 | 148,800,000 | 93,700,000 | 96,500,000 | 77,800,000 | 67,400,000 | 100,000,000 | 98,200,000 | 104,600,000 | 103,500,000 | 93,400,000 | 90,900,000 | 104,800,000 | 99,200,000 | 94,000,000 | 93,200,000 | 96,500,000 | 69,200,000 | 70,700,000 | 70,100,000 | 70,000,000 | 63,900,000 | 68,600,000 | 68,500,000 | 77,700,000 | 60,100,000 | 63,200,000 | 57,400,000 | |||||||||||||||||||
| total liabilities | 734,400,000 | 936,700,000 | 920,000,000 | 1,022,200,000 | 1,026,000,000 | 1,157,100,000 | 1,182,200,000 | 1,311,500,000 | 1,270,300,000 | 1,222,800,000 | 1,247,800,000 | 1,219,400,000 | 1,224,900,000 | 1,183,500,000 | 1,210,200,000 | 1,219,200,000 | 1,205,400,000 | 1,195,600,000 | 1,219,800,000 | 1,128,100,000 | 1,125,700,000 | 1,077,400,000 | 1,133,000,000 | 1,283,800,000 | 1,332,100,000 | 1,388,500,000 | 700,100,000 | 660,100,000 | 631,600,000 | 846,900,000 | 896,200,000 | 485,100,000 | 419,600,000 | 384,400,000 | 469,300,000 | 679,864,000 | 683,265,000 | 782,560,000 | 855,491,000 | 739,797,000 | 757,244,000 | 619,542,000 | 561,534,000 | 535,769,000 | 575,779,000 | 535,920,000 | 525,904,000 | 571,202,000 | 565,515,000 |
| commitments and contingencies | |||||||||||||||||||||||||||||||||||||||||||||||||
| stockholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||
| preferred stock, par value .01, 10,000,000 shares authorized, no shares issued | |||||||||||||||||||||||||||||||||||||||||||||||||
| common stock | 800,000 | 800,000 | 800,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 700,000 | 685,000 | 682,000 | 665,000 | 642,000 | 638,000 | 633,000 | 628,000 | 625,000 | 623,000 | 619,000 | 617,000 | 616,000 | 608,000 | 608,000 |
| additional paid-in capital | 2,793,400,000 | 2,737,700,000 | 2,698,900,000 | 2,647,200,000 | 2,543,100,000 | 2,405,400,000 | 2,549,000,000 | 2,524,300,000 | 2,497,700,000 | 2,457,300,000 | 2,388,400,000 | 2,314,600,000 | 2,291,500,000 | 2,254,200,000 | 2,245,400,000 | 2,225,500,000 | 2,196,500,000 | 2,173,200,000 | 2,148,700,000 | 2,125,700,000 | 2,105,100,000 | 2,068,400,000 | 2,047,900,000 | 2,025,800,000 | 2,001,700,000 | 1,967,600,000 | 1,924,000,000 | 1,903,000,000 | 1,879,500,000 | 1,838,600,000 | 1,785,500,000 | 1,801,400,000 | 1,836,700,000 | 1,826,700,000 | 1,801,100,000 | 1,723,888,000 | 1,694,973,000 | 1,426,998,000 | 1,161,083,000 | 1,101,476,000 | 1,076,061,000 | 1,029,718,000 | 999,681,000 | 1,028,141,000 | 1,013,434,000 | 998,778,000 | 996,773,000 | 959,302,000 | 958,957,000 |
| accumulated other comprehensive loss | -1,200,000 | -3,400,000 | -14,900,000 | -15,600,000 | -12,800,000 | -43,700,000 | -50,600,000 | -38,800,000 | -55,500,000 | -84,100,000 | -65,500,000 | -54,300,000 | -23,000,000 | -20,100,000 | -18,600,000 | -16,800,000 | -14,200,000 | -4,500,000 | -2,100,000 | -3,500,000 | -14,200,000 | -4,100,000 | -5,000,000 | ||||||||||||||||||||||||||
| treasury stock | -3,474,500,000 | -3,474,500,000 | -3,474,500,000 | -3,475,300,000 | -3,443,500,000 | -3,386,100,000 | -2,579,200,000 | -2,579,200,000 | -2,579,200,000 | -2,579,200,000 | -2,579,200,000 | -2,579,200,000 | -2,579,200,000 | -2,579,200,000 | -2,579,200,000 | -2,579,200,000 | -2,579,200,000 | -2,579,200,000 | -2,579,200,000 | -2,579,200,000 | -2,579,200,000 | -2,579,200,000 | -2,579,200,000 | -2,579,200,000 | -2,579,200,000 | ||||||||||||||||||||||||
| retained earnings | 7,853,900,000 | 7,544,400,000 | 7,222,200,000 | 6,920,900,000 | 6,611,800,000 | 6,333,700,000 | 6,027,100,000 | 5,810,000,000 | 5,542,400,000 | 5,283,200,000 | 5,042,300,000 | 4,910,200,000 | 4,670,900,000 | 4,554,900,000 | 4,315,000,000 | 4,202,800,000 | 4,040,100,000 | 3,867,500,000 | 3,839,200,000 | 3,740,400,000 | 3,569,200,000 | 3,462,100,000 | 3,325,200,000 | 3,272,600,000 | 3,140,200,000 | 2,935,100,000 | 3,369,500,000 | 3,263,000,000 | 3,090,100,000 | 2,826,600,000 | 2,550,300,000 | 2,606,300,000 | 2,323,200,000 | 2,161,400,000 | 1,955,300,000 | 1,615,109,000 | 1,150,684,000 | 1,051,473,000 | 952,179,000 | 977,416,000 | 865,564,000 | 758,354,000 | 695,669,000 | 615,805,000 | 470,225,000 | 392,114,000 | 319,798,000 | 205,849,000 | 121,451,000 |
| total stockholders’ equity | 7,173,600,000 | 6,807,200,000 | 6,444,000,000 | 6,100,900,000 | 5,697,200,000 | 5,338,100,000 | 5,984,800,000 | 5,712,100,000 | 5,411,000,000 | 5,123,200,000 | 4,796,700,000 | 4,562,200,000 | 4,318,400,000 | 4,176,300,000 | 3,958,900,000 | 3,829,700,000 | 3,639,500,000 | 3,445,400,000 | 3,395,200,000 | 3,283,100,000 | 3,093,700,000 | 2,948,500,000 | 2,780,400,000 | 2,715,800,000 | 2,558,400,000 | 2,319,000,000 | 2,692,800,000 | 2,565,600,000 | 2,369,400,000 | 2,069,900,000 | 1,776,100,000 | 2,065,300,000 | 1,838,700,000 | 1,806,200,000 | 1,711,800,000 | 1,466,870,000 | 1,040,473,000 | 1,091,623,000 | 1,180,379,000 | 1,173,905,000 | 1,315,547,000 | 1,260,200,000 | 1,165,423,000 | 1,150,704,000 | 1,060,831,000 | 1,009,599,000 | 1,024,649,000 | 1,084,969,000 | 1,002,343,000 |
| total liabilities and stockholders’ equity | 7,908,000,000 | 7,743,900,000 | 7,364,000,000 | 7,123,100,000 | 6,723,200,000 | 6,495,200,000 | 7,167,000,000 | 7,023,600,000 | 6,681,300,000 | 6,346,000,000 | 6,044,500,000 | 5,781,600,000 | 5,543,300,000 | 5,359,800,000 | 5,169,100,000 | 5,048,900,000 | 4,844,900,000 | 4,641,000,000 | 4,615,000,000 | 4,411,200,000 | 4,219,400,000 | 4,025,900,000 | 3,913,400,000 | 3,999,600,000 | 3,898,900,000 | 3,726,700,000 | 3,412,100,000 | 3,244,900,000 | 3,020,200,000 | 2,936,000,000 | 2,691,500,000 | 2,561,300,000 | 2,269,200,000 | 2,201,500,000 | 2,192,100,000 | 2,159,233,000 | 1,736,822,000 | 1,894,614,000 | 2,072,050,000 | 1,952,872,000 | 2,114,934,000 | 1,927,657,000 | 1,777,673,000 | 1,697,355,000 | 1,647,492,000 | 1,556,401,000 | 1,561,435,000 | 1,667,053,000 | 1,578,740,000 |
| accounts receivable, no allowance for 2024 and 2023 | 279,300,000 | 341,800,000 | 290,700,000 | 307,300,000 | |||||||||||||||||||||||||||||||||||||||||||||
| share tracking awards plan | 11,000,000 | 29,400,000 | 29,200,000 | 29,200,000 | 35,400,000 | 40,600,000 | 40,500,000 | 46,300,000 | 80,800,000 | 60,100,000 | 95,300,000 | 65,400,000 | 102,400,000 | 83,500,000 | 96,800,000 | 107,100,000 | 96,800,000 | 32,200,000 | 61,000,000 | 32,000,000 | 25,000,000 | 18,300,000 | 17,700,000 | 77,500,000 | 89,700,000 | 71,700,000 | 82,800,000 | 145,100,000 | 192,000,000 | 218,100,000 | 134,700,000 | 120,900,000 | 142,000,000 | 214,017,000 | 354,779,000 | 392,432,000 | 301,853,000 | 164,427,000 | 207,786,000 | ||||||||||
| commitments and contingencies—note 12 | |||||||||||||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive income | 7,400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| accounts receivable, no allowance for 2023 and 2022 | 278,900,000 | 258,600,000 | 272,700,000 | 134,500,000 | |||||||||||||||||||||||||||||||||||||||||||||
| accounts receivable, no allowance for 2022 and 2021 | 220,400,000 | 231,700,000 | 173,400,000 | 170,500,000 | |||||||||||||||||||||||||||||||||||||||||||||
| accounts receivable, no allowance for 2021 and 2020 | 198,700,000 | 212,800,000 | 173,400,000 | 141,100,000 | |||||||||||||||||||||||||||||||||||||||||||||
| accounts receivable, no allowance for 2020 and 2019 | 157,400,000 | 152,300,000 | 172,000,000 | 149,600,000 | |||||||||||||||||||||||||||||||||||||||||||||
| | |||||||||||||||||||||||||||||||||||||||||||||||||
| series a junior participating preferred stock, par value .01, 100,000 shares authorized, no shares issued | |||||||||||||||||||||||||||||||||||||||||||||||||
| accounts receivable, no allowance for 2019 and 2018 | 151,400,000 | 183,600,000 | 181,000,000 | 159,800,000 | |||||||||||||||||||||||||||||||||||||||||||||
| property, plant and equipment | 738,500,000 | 678,300,000 | 709,300,000 | 701,200,000 | 665,200,000 | 626,100,000 | 577,500,000 | 521,700,000 | 501,900,000 | 493,500,000 | 474,770,000 | 471,862,000 | 474,680,000 | 481,049,000 | 477,534,000 | 474,410,000 | 449,942,000 | 447,893,000 | 449,076,000 | 439,894,000 | 435,751,000 | 401,587,000 | 333,225,000 | 314,945,000 | |||||||||||||||||||||||||
| commitments and contingencies—note 13 | |||||||||||||||||||||||||||||||||||||||||||||||||
| temporary equity | 8,400,000 | 19,200,000 | 19,200,000 | 19,200,000 | 19,200,000 | 19,200,000 | 19,200,000 | 10,900,000 | 10,900,000 | 10,900,000 | 11,000,000 | 12,499,000 | 13,084,000 | 20,431,000 | 36,180,000 | 39,170,000 | 42,143,000 | 47,915,000 | 50,716,000 | ||||||||||||||||||||||||||||||
| accounts receivable, no allowance for 2018 and 2017 | 215,200,000 | 251,300,000 | 211,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| accounts receivable, no allowance for 2017 and 2016 | 251,800,000 | 273,900,000 | 188,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| non-current liabilities | 57,500,000 | 57,400,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| accounts receivable | 224,600,000 | 238,100,000 | 194,800,000 | 179,642,000 | 169,214,000 | 156,153,000 | 139,903,000 | 212,902,000 | 131,771,000 | 130,642,000 | 131,565,000 | 101,347,000 | 108,949,000 | 98,584,000 | 89,150,000 | 87,390,000 | 82,527,000 | ||||||||||||||||||||||||||||||||
| other assets | 169,700,000 | 169,400,000 | 159,800,000 | 153,101,000 | 102,930,000 | 97,499,000 | 98,411,000 | 103,699,000 | 53,076,000 | 53,416,000 | 57,961,000 | 26,596,000 | 28,071,000 | 28,113,000 | 28,050,000 | 22,175,000 | 21,065,000 | ||||||||||||||||||||||||||||||||
| other liabilities | 105,000,000 | 92,000,000 | 112,200,000 | 122,522,000 | 140,851,000 | 135,812,000 | 94,843,000 | 80,724,000 | 95,009,000 | 80,335,000 | 78,989,000 | 81,466,000 | 74,794,000 | 77,499,000 | 82,198,000 | 77,322,000 | 43,045,000 | ||||||||||||||||||||||||||||||||
| convertible notes | 900,000 | 5,400,000 | 30,017,000 | 32,282,000 | 115,222,000 | 224,701,000 | 221,712,000 | 218,739,000 | 212,967,000 | 210,166,000 | 207,379,000 | 201,970,000 | 199,344,000 | 196,733,000 | 248,537,000 | 244,269,000 | |||||||||||||||||||||||||||||||||
| goodwill and other intangibles | 28,533,000 | 28,805,000 | 29,135,000 | 14,499,000 | 15,336,000 | 13,737,000 | 14,614,000 | 14,939,000 | 15,657,000 | 16,662,000 | 17,064,000 | 24,915,000 | 19,402,000 | 9,751,000 | |||||||||||||||||||||||||||||||||||
| commitments and contingencies: | |||||||||||||||||||||||||||||||||||||||||||||||||
| line of credit and mortgages payable—current | 66,614,000 | 141,614,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| marketable investments and cash—restricted | 5,393,000 | 5,355,000 | 5,407,000 | 5,385,000 | 5,348,000 | 5,393,000 | 5,369,000 | 5,123,000 | 5,122,000 | ||||||||||||||||||||||||||||||||||||||||
| mortgages payable—current | 66,614,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| mortgages payable—noncurrent | 3,700,000 | 70,298,000 | 70,320,000 | 70,320,000 | 71,400,000 | 71,415,000 | 71,431,000 | ||||||||||||||||||||||||||||||||||||||||||
| prepaid expenses | 11,147,000 | 12,443,000 | 13,342,000 | 9,762,000 | 10,157,000 | ||||||||||||||||||||||||||||||||||||||||||||
| accounts payable | 9,377,000 | 10,194,000 | 10,130,000 | 8,695,000 | 8,335,000 | 17,244,000 | 17,082,000 | ||||||||||||||||||||||||||||||||||||||||||
| accrued expenses | 81,727,000 | 67,338,000 | 87,635,000 | 67,211,000 | 58,590,000 | 69,628,000 | 61,955,000 | ||||||||||||||||||||||||||||||||||||||||||
| common stock subject to repurchase | 10,882,000 | 10,882,000 | 10,882,000 | 10,882,000 | 10,882,000 | 10,882,000 | |||||||||||||||||||||||||||||||||||||||||||
| series a junior participating preferred stock, par value .01, 100,000 authorized, no shares issued | |||||||||||||||||||||||||||||||||||||||||||||||||
| mortgage payable—noncurrent | 68,929,000 | 68,929,000 |
We provide you with 20 years of balance sheets for United Therapeutics stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of United Therapeutics. Explore the full financial landscape of United Therapeutics stock with our expertly curated balance sheets.
The information provided in this report about United Therapeutics stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.